ALLMedicine™ Hepatitis B Virus Center

Aug 1st, 2021 - Hepatitis B virus (HBV) infection is a worldwide distributing viral disease. Hepatitis due to HBV reactivation may progress to chronic illness and associated with increased risk of hepatic failure and hepatocellular cancer. Rituximab (RTX) is an i...

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Aug 1st, 2021 - Hepatitis B virus (HBV) remains a major global public health problem worldwide; in endemic areas, mother-to-child transmission (MTCT) of HBV is the most common transmission route. Previous studies have shown that amniocentesis for prenatal diagnos...

Aug 1st, 2021 - Although the expenses of liver cirrhosis are covered by a critical illness fund under the current health insurance program in China, the medical costs associated with hepatitis B virus (HBV) related diseases is not well addressed. In order to prov...

Jul 31st, 2021 - Per the well-known resistance of hepatitis B virus (HBV) to nucleos(t)ide analogs, alternative treatment options with higher resistance barriers have been approved for use in both treatment-naïve and lamivudine-resistant HBV infections. This phase...

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Jul 28th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...

Oct 16th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...

Jun 26th, 2018 - HEPATITIS B VIRUS (HBV) IS TRANSMITTED VIA BLOOD OR SEXUAL CONTACT. PERSONS WITH CHRONIC HBV INFECTION ARE AT INCREASED RISK FOR CIRRHOSIS AND LIVER CANCER AND REQUIRE MEDICAL CARE. THIS REPORT UPDATES AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMEND...

Mar 11th, 2020 - Background: Taiwan is one of the area with the highest prevalence of chronic hepatitis B (CHB), and many patients die of hepatitis B virus (HBV)-related cirrhosis or liver cancer that have been the leading causes of death in Taiwan for many years....

Mar 11th, 2020 - This single arm treatment study was conducted by the pediatric centers within the National Institute of Diabetes Digestive and Kidney Diseases (NIDDK)-sponsored Hepatitis B Research Network (HBRN). Children age 3-<18 years with immunotolerant chro...

Jan 6th, 2020 - •Primary Aim: o To describe participants 6 months to <18 years of age with hepatitis B virus (HBV) infection in a prospective cohort in the United States (US) and Canada and identify predictors of disease activation and progression Secondary Aims:...

Jan 6th, 2020 - Aims Primary Aim: o To describe participants with hepatitis B virus (HBV) infection in a prospective cohort in the United States (US) and Canada and identify predictors of disease activation and progression Secondary Aims: To describe clinical, vi...

Jan 2nd, 2020 - Tenofovir Disoproxil Fumarate is a nucleos(t)ide analogue that inhibits Hepatitis B Virus (HBV) growth, and is marketed in Japan with an indication for inhibition of HBV growth in subjects with chronic hepatitis B associated with HBV growth and ab...

Jul 21st, 2021 - NEW YORK (Reuters Health) - RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator, appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study. "These results provide p...

Jun 1st, 2021 - NEW YORK (Reuters Health) - A tri-antigenic hepatitis B vaccine (TAV) effectively prevented hepatitis B virus (HBV) infection in adults, was somewhat more effective than a mono-antigenic vaccine (MAV) comparator, but had higher side effect rates i...

Apr 2nd, 2021 - These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD, MPH, observed at the Gastroenterology Updates, IBD, Liver Disease Conference. That's because the t...

Dec 16th, 2020 - NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for hepatitis B virus (HBV) in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with "moderate certaint...

Aug 26th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...